Multiple Sclerosis Flare (Relapse) – What You Need to Know

What is Multiple Sclerosis Flare?

A multiple sclerosis (MS) flare, also called a relapse or exacerbation, is a sudden worsening of neurologic symptoms that lasts at least 24 hours and cannot be explained by an infection, fever, or other unrelated cause. During a flare, inflammation damages the myelin sheath that surrounds nerve fibers in the brain and spinal cord, temporarily interrupting the transmission of electrical signals. Unlike the gradual progression seen in the primary‑progressive form of MS, flares are usually episodic and can vary in intensity and location.

Most people with relapsing‑remitting MS (RRMS) experience at least one flare per year, especially in the early years after diagnosis. Prompt recognition and treatment are crucial because each untreated flare can leave behind permanent disability.

Common Causes

Flare-ups are not random; certain triggers increase the likelihood of an immune attack on myelin. Below are the most frequently reported precipitants:

• Upper‑respiratory or urinary tract infections – Bacterial or viral infections raise body temperature and stimulate the immune system, both of which can provoke a relapse.
• Fever (including heat exposure) – Known as Uhthoff’s phenomenon, even a modest rise in core temperature can temporarily worsen MS symptoms.
• Stress (emotional or physical) – Chronic stress hormones may alter immune regulation and increase relapse risk.
• Insufficient sleep – Sleep deprivation disrupts cytokine balance, potentially triggering inflammation.
• Vaccinations – Most vaccines are safe, but a small subset of patients report flares after live‑attenuated vaccines; discuss timing with your neurologist.
• Smoking and second‑hand smoke – Tobacco exposure is linked to higher relapse rates and faster disability progression.
• Vitamin D deficiency – Low levels of vitamin D have been associated with increased disease activity.
• Hormonal changes – Pregnancy, menstrual cycles, and menopause can influence immune activity.
• Trauma or surgery – Physical injury or postoperative inflammation can act as a catalyst.
• Non‑adherence to disease‑modifying therapy (DMT) – Missing doses or stopping a DMT removes a key protective barrier against relapses.

Associated Symptoms

The constellation of symptoms during a flare depends on which part of the central nervous system is affected. Commonly reported manifestations include:

• Paresthesias – Numbness, tingling, or “pins‑and‑needles” in the limbs or face.
• Motor weakness – Sudden loss of strength that may affect one side of the body (hemiparesis) or both legs (paraparesis).
• Visual disturbances – Optic neuritis causing blurred vision, loss of color vision, or pain with eye movement.
• Balance and coordination problems – Ataxia, unsteady gait, or difficulty with fine motor tasks.
• Fatigue – Intense, disproportionate tiredness that does not improve with rest.
• Bladder or bowel dysfunction – Urgency, frequency, incontinence, or constipation.
• Cognitive changes – Slowed thinking, memory lapses, or difficulty concentrating.
• Spasticity – Involuntary muscle stiffness or jerking movements.
• Pain – Neuropathic pain described as burning, stabbing, or electric‑shock‑like sensations.
• Speech or swallowing difficulties – Dysarthria or dysphagia during a brain‑stem‑focused flare.

When to See a Doctor

Because early treatment can shorten the flare and reduce permanent damage, it is important to seek medical attention promptly if you notice any of the following:

• New or worsening neurologic symptoms that last >24 hours.
• Sudden loss of vision or eye pain.
• Severe weakness that makes standing or walking unsafe.
• Difficulty speaking, swallowing, or breathing.
• Unexplained fever, urinary tract infection symptoms, or respiratory infection signs.
• Increasing bladder or bowel problems.
• Persistent, severe pain that does not respond to usual medications.

If you already have a neurologist or MS specialist, contact their office immediately; many clinics have “flare hotlines” for urgent assessment.

Diagnosis

Diagnosing a flare is primarily clinical, but objective testing helps to confirm inflammation and rule out mimics.

1. Clinical evaluation

• Neurologic examination focused on strength, sensation, coordination, cranial nerves, and reflexes.
• Review of recent infections, medication changes, stressors, and adherence to DMTs.

2. Magnetic Resonance Imaging (MRI)

Contrast‑enhanced MRI of the brain and/or spinal cord is the gold standard. New gadolinium‑enhancing lesions indicate active inflammation and support the diagnosis of a flare.

3. Lumbar Puncture (spinal tap)

Performed when infection or alternative diagnoses (e.g., neuromyelitis optica) must be excluded. Elevated IgG index or oligoclonal bands may be present but are not specific for a flare.

4. Laboratory tests

• Complete blood count, metabolic panel, and urinalysis to detect infection.
• Serologies for common viruses (e.g., Epstein‑Barr, cytomegalovirus) if indicated.

5. Functional assessments

Tools such as the Expanded Disability Status Scale (EDSS) or Multiple Sclerosis Functional Composite (MSFC) help quantify disability and track change over time.

Treatment Options

Therapy for an MS flare aims to (1) suppress the acute inflammation, (2) speed recovery, and (3) manage symptoms.

1. High‑dose corticosteroids

• Methylprednisolone 1 g IV daily for 3–5 days, or an equivalent oral dose (e.g., prednisone 1 g orally).
• Reduces inflammation and shortens relapse duration by ~30 % (Mayo Clinic, 2023).
• Side effects can include mood changes, insomnia, elevated blood sugar, and stomach irritation – discuss prophylactic measures (e.g., a proton‑pump inhibitor).

**Alternative**: For patients who cannot tolerate IV steroids, oral high‑dose regimens (e.g., 1250 mg oral methylprednisolone) are acceptable.

2. Adrenocorticotropic hormone (ACTH) gel

Used for patients who do not respond to or cannot take high‑dose steroids; administered subcutaneously for 5–7 days (Cleveland Clinic, 2022).

3. Plasma exchange (PLEX)

Considered when steroids fail, especially for severe optic neuritis or transverse myelitis. Typically 5–7 exchanges over 10–14 days improve outcomes in 40‑60 % of cases.

4. Symptom‑specific interventions

• Spasticity – Baclofen, tizanidine, or physical therapy stretching.
• Pain – Gabapentin, pregabalin, or duloxetine for neuropathic pain.
• Fatigue – Amantadine or modafinil, plus energy‑conservation strategies.
• Bladder issues – Anticholinergics, timed voiding, or intermittent catheterization.
• Vision loss – High‑dose steroids plus urgent ophthalmology follow‑up.

5. Disease‑modifying therapies (DMTs)

Long‑term DMTs (e.g., interferon‑β, glatiramer acetate, dimethyl fumarate, fingolimod, ocrelizumab) reduce overall relapse frequency. If flares become frequent, neurologists may switch to a higher‑efficacy agent.

6. Home and lifestyle measures

• Stay well‑hydrated and maintain a balanced diet rich in omega‑3 fatty acids and vitamin D (800–2000 IU/day, per NIH).
• Implement cool‑environment strategies (air‑conditioned rooms, cooling vests) to counteract heat‑related worsening.
• Prioritize sleep – aim for 7–9 hours nightly.
• Use a symptom diary to identify personal triggers.
• Engage in gentle, regular exercise (e.g., swimming, yoga) to maintain strength and flexibility.

Prevention Tips

While not all flares can be avoided, the following strategies lower the overall risk:

• Adhere strictly to prescribed DMTs – Never skip doses without consulting your neurologist.
• Vaccinate appropriately – Annual influenza vaccine and COVID‑19 boosters are recommended for most patients.
• Promptly treat infections – Seek care for urinary or respiratory symptoms early; complete full courses of antibiotics when prescribed.
• Maintain optimal vitamin D levels – Check serum 25‑OH‑vitamin D every 6–12 months; supplement as needed.
• Quit smoking and avoid second‑hand smoke.
• Manage stress – Mindfulness, counseling, or support groups have shown benefit in reducing relapse rates.
• Stay cool – Use cooling garments, avoid hot baths, and limit exposure to direct sunlight during peak hours.
• Regular follow‑up – Routine MRI surveillance assists in detecting subclinical activity.
• Balanced nutrition – Emphasize antioxidants (berries, leafy greens) and limit saturated fats.
• Adequate sleep hygiene – Consistent bedtime, limiting screens before sleep, and treating sleep apnea if present.

Emergency Warning Signs

Key Take‑aways

• A Multiple Sclerosis flare is an acute, inflammatory episode that worsens neurologic function for ≥24 hours.
• Infections, fever, stress, heat, and lapses in disease‑modifying therapy are the most common precipitants.
• High‑dose corticosteroids are the first‑line treatment; plasma exchange is reserved for steroid‑refractory cases.
• Early medical attention, adherence to DMTs, infection prevention, and lifestyle measures substantially reduce relapse frequency and severity.
• Seek emergency care for vision loss, severe weakness, breathing/swallowing difficulty, or fever with neurologic decline.

For personalized advice, always discuss symptoms and treatment options with your neurologist or a qualified healthcare professional. The information above is based on current guidelines from the Mayo Clinic, CDC, NIH, WHO, and peer‑reviewed neurological journals (2022‑2024).